from Global Health Program

Health-care Provision and Health-care Reform in Post-Mao China

April 3, 2014

Testimony
Testimony by CFR fellows and experts before Congress.

More on:

China

Health

An effective strategy to engage China's health-care sector requires the U.S. government to continue promoting business opportunities for U.S. biopharmaceutical firms, hospital groups, and insurance companies, CFR Senior Fellow for Global Health Yanzhong Huang tells the U.S.-China Economic and Security Review Commission. In the meantime, it is also important for the U.S. government and companies to demonstrate the willingness to work with China in addressing health issues of their immediate concern.

More on:

China

Health

Top Stories on CFR

Taiwan

Despite China’s growing pressure, Taiwan has developed one of the world’s strongest democracies—one that will be increasingly tested in the coming years. 

Artificial Intelligence (AI)

Watermarking is often discussed as a solution to the problems posed by AI-generated content. However, watermarking is inadequate without other methods of detecting and sorting out AI-generated content.

RealEcon

Policymakers face complex cost-benefit considerations when intervening in the market to mitigate perceived risks, from climate change to competition with China.